Abstract
The present review outlines the role of breastfeeding in diabetes. In the mother, breastfeeding has been suggested to reduce the incidence of type 2 diabetes mellitus, the metabolic syndrome and cardiovascular disease. Moreover, it appears to reduce the risk of premenopausal breast cancer and ovarian cancer. In the neonate and infant, among other benefits, lactation confers protection from future both type 1 and type 2 diabetes. Whether lactation protects women with gestational diabetes mellitus and their offspring from future T2DM remains to be answered. Importantly, for diabetic mothers, antidiabetic treatment itself may affect breastfeeding. There is not enough data to allow the use of oral hypoglycaemic agents. Therefore, insulin currently remains the optimal antidiabetic treatment during lactation. In conclusion, breastfeeding could be considered a modifiable risk factor for the development of diabetes and even a potential protective lifestyle measure from future cardio-metabolic and malignant diseases. Therefore, health care professionals should encourage both women with and without diabetes to breastfeed their children.
Keywords: Diabetes mellitus, Gestational diabetes mellitus, Hypoglycaemic agents, Insulin, Lactation, Thiazolidinediones, Metabolic Syndrome, Sulfonylureas, Ovarian Cancer, Antidiabetic Treatment, Cardiovascular Disease
Current Diabetes Reviews
Title: Breastfeeding and Diabetes
Volume: 7 Issue: 2
Author(s): E. Gouveri, N. Papanas, A. I. Hatzitolios and E. Maltezos
Affiliation:
Keywords: Diabetes mellitus, Gestational diabetes mellitus, Hypoglycaemic agents, Insulin, Lactation, Thiazolidinediones, Metabolic Syndrome, Sulfonylureas, Ovarian Cancer, Antidiabetic Treatment, Cardiovascular Disease
Abstract: The present review outlines the role of breastfeeding in diabetes. In the mother, breastfeeding has been suggested to reduce the incidence of type 2 diabetes mellitus, the metabolic syndrome and cardiovascular disease. Moreover, it appears to reduce the risk of premenopausal breast cancer and ovarian cancer. In the neonate and infant, among other benefits, lactation confers protection from future both type 1 and type 2 diabetes. Whether lactation protects women with gestational diabetes mellitus and their offspring from future T2DM remains to be answered. Importantly, for diabetic mothers, antidiabetic treatment itself may affect breastfeeding. There is not enough data to allow the use of oral hypoglycaemic agents. Therefore, insulin currently remains the optimal antidiabetic treatment during lactation. In conclusion, breastfeeding could be considered a modifiable risk factor for the development of diabetes and even a potential protective lifestyle measure from future cardio-metabolic and malignant diseases. Therefore, health care professionals should encourage both women with and without diabetes to breastfeed their children.
Export Options
About this article
Cite this article as:
Gouveri E., Papanas N., I. Hatzitolios A. and Maltezos E., Breastfeeding and Diabetes, Current Diabetes Reviews 2011; 7 (2) . https://dx.doi.org/10.2174/157339911794940684
DOI https://dx.doi.org/10.2174/157339911794940684 |
Print ISSN 1573-3998 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6417 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Oxidative Stress Genes, Antioxidants and Coronary Artery Disease in Type 2 Diabetes Mellitus
Cardiovascular & Hematological Agents in Medicinal Chemistry Neurological Disorders in Pregnancy
Current Women`s Health Reviews The Effect of Probiotics Supplementation on Maternal-Fetal Care
Current Women`s Health Reviews Thiazolidinediones and Type 2 Diabetes: From Cellular Targets to Cardiovascular Benefit
Current Drug Targets The Fetal Origins of Obesity: Early Origins of Altered Food Intake
Endocrine, Metabolic & Immune Disorders - Drug Targets Why is the Incidence of Type 1 Diabetes Increasing?
Current Diabetes Reviews Retinal Neurodegeneration in the Course of Diabetes-Pathogenesis and Clinical Perspective
Current Neuropharmacology Gene Expression Profiling in Rodent Models for Schizophrenia
Current Neuropharmacology Membrane Ion Channels and Diabetes
Current Pharmaceutical Design Fetal and Early-Postnatal Developmental Patterns of Obese-Genotype Piglets Exposed to Prenatal Programming by Maternal Over- and Undernutrition
Endocrine, Metabolic & Immune Disorders - Drug Targets Cyclopentenyl Cytosine (CPEC): An Overview of its in vitro and in vivo Activity
Current Cancer Drug Targets The Management of Gestational Diabetes
Current Diabetes Reviews Acrylamide Induced Toxicity and the Propensity of Phytochemicals in Amelioration: A Review
Central Nervous System Agents in Medicinal Chemistry Nicotinamide Supplementation Protects Gestational Diabetic Rats by Reducing Oxidative Stress and Enhancing Immune Responses
Current Medicinal Chemistry B Lymphocytes Are Predictors of Insulin Resistance in Women with Gestational Diabetes Mellitus
Endocrine, Metabolic & Immune Disorders - Drug Targets Beneficiary and Adverse Effects of Phytoestrogens: A Potential Constituent of Plant-based Diet
Current Pharmaceutical Design Type 1 Diabetes in Pregnancy: A Review of Complications and Management
Current Diabetes Reviews Current Reviews on Renal Vein Thrombosis in Neonates
Current Pediatric Reviews CRH Receptor Signalling: Potential Roles in Pathophysiology
Current Molecular Pharmacology Perinatal and Neonatal Outcomes of Lithium-Treated and Untreated Bipolar Women During Pregnancy: A Review of Present Literature
Current Psychopharmacology